Goldman Sachs’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$693K Sell
202,029
-92,214
-31% -$316K ﹤0.01% 4073
2025
Q1
$871K Sell
294,243
-19,854
-6% -$58.8K ﹤0.01% 3909
2024
Q4
$958K Buy
314,097
+8,379
+3% +$25.6K ﹤0.01% 3942
2024
Q3
$780K Buy
305,718
+105,134
+52% +$268K ﹤0.01% 3897
2024
Q2
$654K Sell
200,584
-249,996
-55% -$815K ﹤0.01% 3816
2024
Q1
$2.39M Buy
450,580
+334,625
+289% +$1.77M ﹤0.01% 3099
2023
Q4
$502K Buy
115,955
+31,811
+38% +$138K ﹤0.01% 3950
2023
Q3
$221K Buy
84,144
+10,230
+14% +$26.9K ﹤0.01% 4222
2023
Q2
$261K Sell
73,914
-90
-0.1% -$318 ﹤0.01% 4296
2023
Q1
$229K Sell
74,004
-2,447
-3% -$7.56K ﹤0.01% 4464
2022
Q4
$323K Sell
76,451
-43,081
-36% -$182K ﹤0.01% 4316
2022
Q3
$284K Sell
119,532
-101,360
-46% -$241K ﹤0.01% 4571
2022
Q2
$629K Sell
220,892
-218,942
-50% -$623K ﹤0.01% 4233
2022
Q1
$1.27M Sell
439,834
-1,843,331
-81% -$5.31M ﹤0.01% 3944
2021
Q4
$6.94M Buy
2,283,165
+1,475,239
+183% +$4.48M ﹤0.01% 2557
2021
Q3
$5.66M Buy
807,926
+421,366
+109% +$2.95M ﹤0.01% 2698
2021
Q2
$3.55M Sell
386,560
-438,902
-53% -$4.03M ﹤0.01% 3049
2021
Q1
$8.02M Buy
825,462
+127,529
+18% +$1.24M ﹤0.01% 2350
2020
Q4
$7.16M Sell
697,933
-209,147
-23% -$2.15M ﹤0.01% 2249
2020
Q3
$9.15M Sell
907,080
-77,600
-8% -$783K ﹤0.01% 2005
2020
Q2
$10.3M Buy
984,680
+291,227
+42% +$3.04M ﹤0.01% 1930
2020
Q1
$5.85M Sell
693,453
-74,616
-10% -$630K ﹤0.01% 2147
2019
Q4
$6.72M Sell
768,069
-217,913
-22% -$1.91M ﹤0.01% 2257
2019
Q3
$10.6M Buy
985,982
+465,063
+89% +$5.01M ﹤0.01% 1896
2019
Q2
$6.62M Sell
520,919
-191,182
-27% -$2.43M ﹤0.01% 2152
2019
Q1
$27.6M Buy
712,101
+366,594
+106% +$14.2M 0.01% 1391
2018
Q4
$7.03M Buy
345,507
+101,932
+42% +$2.07M ﹤0.01% 2114
2018
Q3
$11.2M Buy
243,575
+5,346
+2% +$245K ﹤0.01% 1988
2018
Q2
$14.1M Buy
238,229
+49,483
+26% +$2.93M ﹤0.01% 1832
2018
Q1
$12.8M Sell
188,746
-311,640
-62% -$21.2M ﹤0.01% 1787
2017
Q4
$49.5M Buy
500,386
+2,232
+0.4% +$221K 0.01% 1090
2017
Q3
$59.7M Buy
498,154
+23,437
+5% +$2.81M 0.01% 967
2017
Q2
$41.5M Buy
474,717
+158,636
+50% +$13.9M 0.01% 1124
2017
Q1
$11.8M Buy
316,081
+140,814
+80% +$5.24M ﹤0.01% 1772
2016
Q4
$5.38M Buy
175,267
+19,771
+13% +$607K ﹤0.01% 2142
2016
Q3
$10.4M Buy
155,496
+21,774
+16% +$1.46M ﹤0.01% 1828
2016
Q2
$3.98M Buy
133,722
+42,649
+47% +$1.27M ﹤0.01% 2254
2016
Q1
$2.68M Sell
91,073
-111,497
-55% -$3.27M ﹤0.01% 2375
2015
Q4
$15.9M Buy
202,570
+134,690
+198% +$10.6M 0.01% 1457
2015
Q3
$5.12M Sell
67,880
-144,070
-68% -$10.9M ﹤0.01% 2005
2015
Q2
$24.7M Buy
211,950
+47,098
+29% +$5.5M 0.01% 1244
2015
Q1
$38.9M Buy
164,852
+135,606
+464% +$32M 0.01% 993
2014
Q4
$5.54M Buy
29,246
+5,996
+26% +$1.13M ﹤0.01% 1926
2014
Q3
$5.55M Sell
23,250
-14,492
-38% -$3.46M ﹤0.01% 1918
2014
Q2
$2.49M Buy
37,742
+31,268
+483% +$2.06M ﹤0.01% 2413
2014
Q1
$674K Buy
6,474
+3,633
+128% +$378K ﹤0.01% 3209
2013
Q4
$294K Sell
2,841
-18,357
-87% -$1.9M ﹤0.01% 3706
2013
Q3
$1.14M Buy
21,198
+11,016
+108% +$591K ﹤0.01% 2862
2013
Q2
$452K Buy
+10,182
New +$452K ﹤0.01% 3225